Hilmi M - Search Results

1

Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.

Hamza A, Masliah-Planchon J, Neuzillet C, Lefèvre JH, Svrcek M, Vacher S, Bourneix C, Delaye M, Goéré D, Dartigues P, Samalin E, Hilmi M, Lazartigues J, Girard E, Emile JF, Rigault E, Dangles-Marie V, Rioux-Leclercq N, de la Fouchardière C, Tougeron D, Casadei-Gardini A, Mariani P, Peschaud F, Cacheux W, Lièvre A, Bièche I. Hamza A, et al. Among authors: hilmi m. Int J Cancer. 2024 Feb 1;154(3):504-515. doi: 10.1002/ijc.34781. Epub 2023 Oct 31. Int J Cancer. 2024. PMID: 37908048 Free article.

2

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.

Hilmi M, Bally C, Burns R, Lorillon G, Bergeron A, Fenaux P, Ades L. Hilmi M, et al. Ann Hematol. 2018 Mar;97(3):541-542. doi: 10.1007/s00277-017-3190-8. Epub 2017 Nov 23. Ann Hematol. 2018. PMID: 29170809 No abstract available.

3

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?

Hilmi M, Bartholin L, Neuzillet C. Hilmi M, et al. World J Gastroenterol. 2018 May 28;24(20):2137-2151. doi: 10.3748/wjg.v24.i20.2137. World J Gastroenterol. 2018. PMID: 29853732 Free PMC article. Review.

4

Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?

Hilmi M, Jouinot A, Burns R, Pigneur F, Mounier R, Gondin J, Neuzillet C, Goldwasser F. Hilmi M, et al. Pharmacol Ther. 2019 Apr;196:135-159. doi: 10.1016/j.pharmthera.2018.12.003. Epub 2018 Dec 4. Pharmacol Ther. 2019. PMID: 30521882

5

[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research].

Hilmi M, Rousseau B, Cohen R, Vienot A, Vernerey D, Bartholin L, Blanc-Durand F, Louvet C, Turpin A, Neuzillet C. Hilmi M, et al. Bull Cancer. 2019 May;106(5):407-420. doi: 10.1016/j.bulcan.2019.02.009. Epub 2019 Apr 12. Bull Cancer. 2019. PMID: 30987751 French.

6

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.

Hilmi M, Neuzillet C, Calderaro J, Lafdil F, Pawlotsky JM, Rousseau B. Hilmi M, et al. J Immunother Cancer. 2019 Nov 29;7(1):333. doi: 10.1186/s40425-019-0824-5. J Immunother Cancer. 2019. PMID: 31783782 Free PMC article. Review.

7

Immune Therapy for Liver Cancers.

Hilmi M, Vienot A, Rousseau B, Neuzillet C. Hilmi M, et al. Cancers (Basel). 2019 Dec 27;12(1):77. doi: 10.3390/cancers12010077. Cancers (Basel). 2019. PMID: 31892230 Free PMC article. Review.

8

Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary survey.

Hilmi M, Pellat A, Benoit O, Foucaut AM, Mino JC, Kauffmann A, Rochet F, Heuze E, Pudlarz T, Naoun N, Garcia-Larnicol ML, Delpeut C, Peschaud F, Neuzillet C. Hilmi M, et al. BMJ Support Palliat Care. 2020 Sep;10(3):324-330. doi: 10.1136/bmjspcare-2020-002342. Epub 2020 Jul 14. BMJ Support Palliat Care. 2020. PMID: 32665258

9

[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation].

Hilmi M, Neuzillet C. Hilmi M, et al. Bull Cancer. 2020 Oct;107(10):961-962. doi: 10.1016/j.bulcan.2020.06.009. Epub 2020 Sep 14. Bull Cancer. 2020. PMID: 32943226 French. No abstract available.

10

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion.

Hilmi M, Nicolle R, Bousquet C, Neuzillet C. Hilmi M, et al. Cancers (Basel). 2020 Oct 14;12(10):2969. doi: 10.3390/cancers12102969. Cancers (Basel). 2020. PMID: 33066357 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters